Your session is about to expire
← Back to Search
The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children
N/A
Waitlist Available
Led By Margaret Cupit-Link, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial uses a special scale to measure how much nausea and vomiting children with cancer experience during chemotherapy. The goal is to help doctors give the right anti-nausea medications to make the children feel better.
Eligible Conditions
- Nausea and Vomiting
- Nausea
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BARF scaleExperimental Treatment1 Intervention
* Nursing staff (which may include patient technicians and nursing assistants) will use the scale to assess the patient's nausea for the entire duration of the admission. These assessments will take place in conjunction with vital sign monitoring, every 4 hours. The associated script will be read while the laminated scale is shown to the patient.
* The nurse will then log the patient's response in the patient's electronic medical record
Group II: No interventionActive Control1 Intervention
-Patients in the control group will proceed with their inpatient chemotherapy admissions without any interventions. These admissions will take place prior to the admissions of the experimental group, so as not to bias providers.
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,997 Previous Clinical Trials
2,298,755 Total Patients Enrolled
Margaret Cupit-Link, M.D.Principal InvestigatorWashington University School of Medicine
Amy Armstrong, M.D.Principal InvestigatorWashington University School of Medicine